Seminari I dottorandi sono tenuti a frequentare i seminari organizzati, autonomamente o in coordinamento con altri Dottorati, dal Dottorato in "Innovation in immunomediated disease and hematological disorders".E' inoltre fortemente consigliata la partecipazione alle numerose altre attività di divulgazione scientifica proposte nel corso dell'anno.A fianco il programma dei seminari dell'Accademia Medica e la programmazione del Dottorato di Medicina Molecolare in collaborazione con altri Dottorati. 2025 2024 Seminari Accademia Medica di Roma:“Learning about slan+-monocytes while working on neutrophils, and viceversa” 31 Gennaio 2024 Accademia Medica di Roma.“Effetti immunitari pleiotropici del vaccino mRNA per COVID-19” 17 Gennaio 2024 High-dimensional single-cell based approaches to decipher the cancer-innate immune axis 12 Gennaio 2024 Seminari Accademia Medica di Roma: “Immune-mediated inflammatory diseases: common and different pathogenic and clinical features” 10 Gennaio 2024 2023 Seminari IRE-Sapienza: The influence of the tumor immune microenvironment in colorectal carcinoma progression 13 Dicembre 2023 FlowJo™ Software v10 Training 13 Novembre 2023 Seminari IRE: Reprogramming tumour-associated macrophages with nanomedicine-based immunotherapies 26 Ottobre 2023 Potenziamento delle attività salutari di cibi funzionali: il Solanum Lycopersicum come modello esplorativo per le malattie infiammatorie cronico-degenerative 12 Settembre 2023 AIRC LECTURE: THE LEADING ROLE OF THEACADEMIC RESEARCH IN THE FIGHT AGAINST BREAST CANCER 14 Luglio 2023 Clinical oncology is a research-driven specialty and demonstrating benefi t through clinical trialsis how we improve care for our patients. Research based on randomized clinical trials funded by the industry has undeniably producedprogress in the quantity and quality of care, making it possible to develop and register drugsthat have a great clinical impact. Many unsolved issues are not of interest to pharmaceutical companies and are addressed onlyby academic clinical trials. Academic studies do not aim to register or market new drugs but aimto improve the overall treatment by evaluation of issues such as multimodal therapies,comparisons between diff erent drugs and diff erent drug combinations, management of sideeff ects. Researchers do create collaborative networks, ie Academic Research Organizations, to conductclinical trials necessary to fi nd answers to important medical questions. Seminari dei Dottorati di Ricerca dei Dipartimenti di Medicina Molecolare e Medicina Sperimentale: “Bridging the defects in neural cells: mitochondria and lysosomes. The role of lipid rafts” 5 Luglio 2023 Metabolic features of myelopiesis in cancer 28 Giugno 2023 Seminario congiunto dottorati Medicina Molecolare e Medicina Sperimentale: "“50 Years with NK cells" 20 Giugno 2023 New and old aspects of cancer immunotherapy 9 Giugno 2023 Seminario congiunto dottorati Medicina Molecolare e Medicina Sperimentale: “Innate lymphoid cell subsets in Cancer and Viral infections” 6 Giugno 2023 123 2022 Glucocorticoid regulation of ILCs function 12 Dicembre 2022 Autoimmune manifestations following immune checkpoint blockade 16 Novembre 2022 NPM1-mutated AML: from bench to bedside, and viceversa 15 Giugno 2022 JAK/STAT signals underlying innate lymphoid cell homeostasis and activation 7 Giugno 2022 Immunoncologia di precisione: identikit del paziente per guidare scelte terapeutiche 10 maggio 2022 IL MONITORAGGIO IMMUNOLOGICO DELLE PATOLOGIE ONCOEMATOLOGICHE NEGLI ANNI ’20 5 Maggio 2022 Role of the atypical chemokine receptor ACKR2 in the immune response to tumors 20 Aprile 2022 Mieloma Multiplo: modulazione del microambiente tumorale e strategie di stimolazione del sistema immunitario 12 Aprile 2022 The role of autophagy in cardiovascular diseases 22 Marzo 2022 RNA circolari nel differenziamento e nelle malattie 17 Marzo 2022 12 2021 A centrosomal route for cancer and other diseases 9 Dicembre 2021 Nuovi meccanismi che favoriscono il reclutamento di cellule natural killer nei tumori: implicazioni terapeutiche 18 Novembre 2021 Epitranscriptomic and non-coding RNAs in the control of gene expression and tumor microenvironment 04/11/2021 WEBINAR GUIDO POLI & ELISA VICENZI, Unisr, Milan "Emerging viruses" 14/4 /2020 “Adattamento piastrinico alla terapia antiaggregante” 15.12.2021 “Synthesis and function of queuosine, the forgotten micronutrient” 16.09.2021 Corso di Statistica 29.09.21/30.09.21 Modulation of epigenetically controlled gene transcription and cell states by small molecules 19 .07.21 The role of scaffolding and enzymatic activity in kinase signalling. Lessons from studies with selective small molecule inhibitors. 16.07.21 From autologous to allogenic CAR products: the journey of CAR T therapy for hematological malignancies, 07.07.21 123 2020 Novel technologies for human vaccines 30/4/2020 Adaptive immunity to viruses 28/4/2020 Adaptive immunity to viruses 28/4/2020 Innate immunity to viruses 24/04/2020 High dimensional data analysis with FlowJo 24/4/2020 Innate immunity to viruses 24/4/2020 An overview of immune response to viruses 21/4/2020 "Virus-host interaction" 17/4/2020 Emerging viruses 14/4/2020 " Canonical and non canonical roles of the complement system" 15/07/2020 12 2019 Workshop “Network medicine 11/04/2019 Short term and long term effects of interferons and influenza on lung immunity 11/04/2019 11/04/19 10/10/2019 09/05/19 Interplay between oncogenic signaling, tumor stroma and metabolism in cancer development 7/02/2019 Conferenza sull’Antibiotico Resistenza e le sue soluzioni, con particolare focus sulla situazione Italiana 6/04/2019 04/07/19 UNIVAX DAY 2019 1/2/2019 BeMM Symposium, PhD School Symposium, PhD School of Biology and Molecular Medicine 22 novembre 2019 9:00 am 1234 2018 Immunological aspects and pathogenesis of HBV and HCV associated liver damage 12/07/2018 Il linfoma di Burkitt: epidemiologia e patogenesi 12/04/2018 9th BeMM Symposium (Biology and Molecular Medicine PhD School Symposium) 13/11/2018 Innate and adaptive immune control of oncogenic gamma-herpesviruses 11/07/2018 Can viruses teach us to make better vaccines? Immune response to cytomegalovirus expressing cellular ligands for innate immune receptors. 11/07/2018 Human T Cell Leukemia: Mechanisms of Oncogenesis, Pathogenesis and Immune Evasion 10/07/2018 HIV persistence in the antiretroviral therapy era: when, where and how does HIV hide? 10/07/2018 Virus hijacking of host innate immune responses 9/07/2018 Sclerosi multipla, risposta immunitaria e virus di Epstein Barr: interazioni pericolose 8/3/2018 Clinical utility of novel biomarkers for cardiovascular disease risk stratification and prediction in children” 18/06/2018 123